Ji-Lin Dai1, Yun Lin2, Yong-Jian Yuan1, Shi-Tong Xing1, Yi Xu1, Qiang-Hua Zhang1, Ji-Kang Min1. 1. a Department of Orthopaedic , Huzhou First People's Hospital of Zhejiang Province , Huzhou City 313000 , China. 2. b Department of Editor , Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital , Chengdu 610072 , China.
Abstract
OBJECTIVE: The present study was aimed to investigate the therapeutic potential of neuroglobin in the recovery of spinal cord injury. METHODS: The male albino Wistar strain rats were used as an experimental model, and adeno associated virus (AAV) was administered in the T12 section of spinal cord ten days prior to the injury. Basso Beattie Bresnahan (BBB) locomotor rating scale was used to determine the recovery of the hind limb during four weeks post-operation. Malondialdehyde (MDA), catalase and superoxide dismutase (SOD) were determined in the spinal cord tissues. Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay was carried out to determine the presence of apoptotic cells. Immunofluorescence analysis was carried out to determine the neuroglobin expression. Western blot analysis was carried out to determine the protein expressions of caspase-3, cytochrome c, bax and bcl-2 in the spinal cord tissues. RESULTS: Experimental results showed that rats were recovered from the spinal cord injury due to increased neuroglobin expression. Lipid peroxidation was reduced, whereas catalase and SOD activity were increased in the spinal cord tissues. Apoptosis and lesions were significantly reduced in the spinal cord tissues. Caspase-3, cytochrome c and bax levels were significantly reduced, whereas bcl-2 expression was reduced in the spinal cord tissues. CONCLUSION: Taking all these data together, it is suggested that the increased neuroglobin expression could improve the locomotor function.
OBJECTIVE: The present study was aimed to investigate the therapeutic potential of neuroglobin in the recovery of spinal cord injury. METHODS: The male albino Wistar strain rats were used as an experimental model, and adeno associated virus (AAV) was administered in the T12 section of spinal cord ten days prior to the injury. Basso Beattie Bresnahan (BBB) locomotor rating scale was used to determine the recovery of the hind limb during four weeks post-operation. Malondialdehyde (MDA), catalase and superoxide dismutase (SOD) were determined in the spinal cord tissues. Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay was carried out to determine the presence of apoptotic cells. Immunofluorescence analysis was carried out to determine the neuroglobin expression. Western blot analysis was carried out to determine the protein expressions of caspase-3, cytochrome c, bax and bcl-2 in the spinal cord tissues. RESULTS: Experimental results showed that rats were recovered from the spinal cord injury due to increased neuroglobin expression. Lipid peroxidation was reduced, whereas catalase and SOD activity were increased in the spinal cord tissues. Apoptosis and lesions were significantly reduced in the spinal cord tissues. Caspase-3, cytochrome c and bax levels were significantly reduced, whereas bcl-2 expression was reduced in the spinal cord tissues. CONCLUSION: Taking all these data together, it is suggested that the increased neuroglobin expression could improve the locomotor function.
Authors: Brooke R Snyder; Steven J Gray; Eric T Quach; Jeremiah W Huang; Cary H Leung; R Jude Samulski; Nicholas M Boulis; Thais Federici Journal: Hum Gene Ther Date: 2011-07-25 Impact factor: 5.695
Authors: D M Basso; M S Beattie; J C Bresnahan; D K Anderson; A I Faden; J A Gruner; T R Holford; C Y Hsu; L J Noble; R Nockels; P L Perot; S K Salzman; W Young Journal: J Neurotrauma Date: 1996-07 Impact factor: 5.269
Authors: Adil A Khan; Yaoming Wang; Yunjuan Sun; Xiao Ou Mao; Lin Xie; Erin Miles; Justin Graboski; Sylvia Chen; Lisa M Ellerby; Kunlin Jin; David A Greenberg Journal: Proc Natl Acad Sci U S A Date: 2006-11-10 Impact factor: 11.205
Authors: E De Marinis; E Acaz-Fonseca; M A Arevalo; P Ascenzi; M Fiocchetti; M Marino; L M Garcia-Segura Journal: J Neuroendocrinol Date: 2013-03 Impact factor: 3.627
Authors: Sawsan Abuhamdah; Tahia H Saleem; Bakheet E M Elsadek; Omyma Ashraf; Ali R Hamdan; Eslam El Sayed El-Khateeb; Saeda M Abd Elwahab; Mohammed H Hassan Journal: Int J Gen Med Date: 2022-06-25